Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
CA 2369319 A1 · Owner: Eos Biotechnology, Inc. · Inventors: Mack, David; Gish, Kurt C.; Wilson, Keith E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 15, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 15, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 15, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.